New, Effective Hyperkalemia Management and Enabling Optimal RAASi Therapy Patient Health Management (PHM) Program

MENA

$0

free

Unaccredited

1.5 hr

Cardiovascular

0 Credits

Course Description

Duration: 1.5 hr | Sponsor: Vifor Pharma

This Patient Health Management program will allow physicians to gain enhanced practical knowledge and insights into new best practices to safely and effectively manage hyperkalemia, avoiding episodic and dangerous outcomes. 

Step 1: Complete the 1-hour CME course 

Using patient case studies, this CME course reviews best practice scenarios for using improved potassium lowering medication regimens to decrease risk and prevent complications associated with hyperkalemia  

Step 2: Physician Screening Tool 

Complete a screening questionnaire to provide an overview of your practice experience and a broad picture of your current treatment approaches for hyperkalemia.  

Step 3: Reflective Survey 

The Reflective Survey will provide you with a brief and targeted review of the key learnings, helping you to consider how you’ve incorporated the knowledge gained over the course of the program 

This material has been developed with educational support from CSL Vifor.

Course Details

Expiry Date: 2023-02-28

Professions: Specialist

Faculty

Amal Najrani, MD, MOH  

Saeed Al Ahmari, MBBs, MRCP (UK) 

Javed Butler, MD, MPH, MBA  

David Strain, MB, ChB, BSc (Hons), MD, FRCP  

Accreditation

Learning Objective(s)

After completion of this PHM, participants will be better able to:  

  1. Outline the causes of hyperkalemia, the burden of disease, and its impact of morbidity and mortality  
  2. Describe the role potassium-binder therapy (with new agents) versus traditional therapy in the management of hyperkalemia  
  3. Review the considerations for making treatment choices, including the benefits of maintaining optimal RAASi therapy and dosing  
  4. Identify specific at-risk patient types and apply the latest recommendations for treatment and management of hyperkalemia